TY  - JOUR
AU  - Masri, Ahmad
AU  - Sherrid, Mark V
AU  - Abraham, Theodore P
AU  - Choudhury, Lubna
AU  - Garcia-Pavia, Pablo
AU  - Kramer, Christopher M
AU  - Barriales-Villa, Roberto
AU  - Owens, Anjali T
AU  - Rader, Florian
AU  - Nagueh, Sherif F
AU  - Olivotto, Iacopo
AU  - Saberi, Sara
AU  - Tower-Rader, Albree
AU  - Wong, Timothy C
AU  - Coats, Caroline J
AU  - Watkins, Hugh
AU  - Fifer, Michael A
AU  - Solomon, Scott D
AU  - Heitner, Stephen B
AU  - Jacoby, Daniel L
AU  - Kupfer, Stuart
AU  - Malik, Fady I
AU  - Meng, Lisa
AU  - Sohn, Regina L
AU  - Wohltman, Amy
AU  - Maron, Martin S
PY  - 2024
DO  - 10.1016/j.cardfail.2024.02.020
UR  - http://hdl.handle.net/20.500.12105/20368
AB  - BACKGROUNDThis open-label phase 2 trial evaluated the safety and efficacy of aficamten in patients with nonobstructive hypertrophic cardiomyopathy (nHCM).METHODSPatients with symptomatic nHCM (left ventricular outflow tract obstruction gradient ≤ 30...
LA  - eng
PB  - Elsevier
TI  - Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.
TY  - journal article
ER  -